GB762976A - Erythromycin b and acid addition salts thereof - Google Patents
Erythromycin b and acid addition salts thereofInfo
- Publication number
- GB762976A GB762976A GB1867/54A GB186754A GB762976A GB 762976 A GB762976 A GB 762976A GB 1867/54 A GB1867/54 A GB 1867/54A GB 186754 A GB186754 A GB 186754A GB 762976 A GB762976 A GB 762976A
- Authority
- GB
- United Kingdom
- Prior art keywords
- erythromycin
- nrrl
- solvent
- culture medium
- extraction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
- C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
- C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/465—Streptomyces
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Erythromycin B is produced by cultivating an erythromycin - B - producing strain of Streptomyces erythreus in a culture medium containing an assimilable source of carbohydrate, nitrogen and inorganic salts under submerged aerobic conditions until substantial antibiotic activity is produced by said organism in said culture medium and extracting the filtered medium with a waterimmiscible polar solvent, removing the solvent and separating the erythromycin B by countercurrent extraction from any erythromycin present. Suitable micro-organisms are S. erythreus strains NRRL 2338 (preferred), NRRL 2359, NRRL 2360 and NRRL 2361. The culture medium and conditions of culture are similar to those employed in Specification 708,159 for the preparation of erythromycin per se. Specified water-immiscible polar solvents are alkyl esters of fatty acids, e.g. ethyl acetate and amyl acetate; chlorinated hydrocarbons, e.g. chloroform and ethylene dichloride; alcohols, e.g. butanol and pentanol; ketones, e.g. methyl amyl ketone, ethyl ether and dibutyl ether. Preferably the filtered broth is adjusted to at least pH 9.5 before extraction with the polar solvent. Erythromycin B is separated from erythromycin by (a) adsorption and e.g. purified cellulose fibre followed by selective elution with e.g. aqueous ammonia saturated with methyl isobutyl ketone; or (b) extraction in a Craig countercurrent apparatus using as solvent a mixture of methyl isobutyl ketone, 0.1 M phosphate buffer at pH 6.5 and acetone. Erythromycin B is a nitrogenous base forming salts <FORM:0762976/IV(b)/1> <FORM:0762976/IV(b)/2> with acids; in 2 : 1 dimethylformamide-water solution pK1a of 8.5; molecular weight of about 736; infra-red absorption spectrum of chloroform solution shows absorption maxima at 2.80; 3.34; 5.80; 5.90; 6.84; 7.24; 7.50; 7.79; 8.04; 8.54; 8.98; 9.14; 9.48; 9.86; 10.24; 10.56; 10.96; 11.22; 11.54 and 11.94 microns. Specified salts are the hydrochloride, sulphate, citrate, mandelate, succinate, oleate, palmitate, myristate, stearate, oxalate, thiocyanate and glucoheptanate.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US762976XA | 1953-07-29 | 1953-07-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB762976A true GB762976A (en) | 1956-12-05 |
Family
ID=22131095
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1867/54A Expired GB762976A (en) | 1953-07-29 | 1954-01-21 | Erythromycin b and acid addition salts thereof |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB762976A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1266905A1 (en) * | 2000-03-22 | 2002-12-18 | Chugai Seiyaku Kabushiki Kaisha | Process for producing purified erythromycin |
-
1954
- 1954-01-21 GB GB1867/54A patent/GB762976A/en not_active Expired
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1266905A1 (en) * | 2000-03-22 | 2002-12-18 | Chugai Seiyaku Kabushiki Kaisha | Process for producing purified erythromycin |
EP1266905A4 (en) * | 2000-03-22 | 2003-05-07 | Chugai Pharmaceutical Co Ltd | Process for producing purified erythromycin |
US6767998B2 (en) | 2000-03-22 | 2004-07-27 | Chugai Seiyaku Kabushiki Kaisha | Method for preparing purified erythromycin |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE68921934T2 (en) | Immunosuppressive agent. | |
US3326759A (en) | Antibiotics macrocin and lactenocin | |
US2928844A (en) | Celesticetin, its salts and method of preparation | |
ES373632A1 (en) | Process for the preparation of daunorubicin | |
GB1357538A (en) | New antibiotic | |
US2990329A (en) | Preparation of ristocetin a salts | |
GB762976A (en) | Erythromycin b and acid addition salts thereof | |
GB935075A (en) | The antibiotic decoyinine and the manufacture thereof | |
GB1116280A (en) | Antibiotic a28829 | |
US2787580A (en) | Process of producing antibiotic p. a. 114 | |
US2806024A (en) | Erythromycin b and process for production thereof | |
US3074855A (en) | Process for preparing naramycin a and its isomer | |
GB901273A (en) | The new organic compound tylosin, its hydrolysis product desmycosin and methods for preparing same | |
Perlman et al. | Preparation of amphotericin B‐14C | |
GB811757A (en) | Production of an antibiotic designated antibiotic 101a fermentation | |
IL42700A (en) | Antibiotic g-52 and method for the production thereof | |
KR840005742A (en) | Preparation of antimicrobial and antitumor antibiotic M9026 and its pure fractions 1,2 and 3 | |
US3125566A (en) | Process for obtaining novobiocin | |
US3023145A (en) | Protomycin and its production | |
GB708159A (en) | A new antibiotic (erythromycin) and a process for preparing same | |
US3819834A (en) | Espinomycin antibiotics and methods of preparing same | |
GB729208A (en) | Improvements in or relating to a new antibiotic p.a. 95 and the preparation thereof | |
US2970943A (en) | Valacidin and processes for the preparation thereof | |
US3917514A (en) | Process for preparing the antibiotic S 15-1 | |
US3743635A (en) | 27-demethoxy-27-hydroxyrifamycin derivatives |